Table 2.
Body composition parameters changes during neoadjuvant therapy.
| Parameter | Pre NAT | Post NAT | Delta | 95% CI | p-value |
|---|---|---|---|---|---|
| BMI, kg/m2 | 24.0 (4.1) | 23.8 (4.0) | −0.14 (1.46) | −1.3, 0.60 | 0.5 |
| SMA, cm2 | 133 (58) | 134 (51) | 1.2 (16) | −12, 8.5 | 0.7 |
| SMI, cm2/m2 | 52 (32) | 49 (16) | 0.34 (13.54) | −13, −2.6 | 0.003 |
| VAT, cm2 | 121 (124) | 103 (108) | −8.7 (40.1) | −30, 9.4 | <0.001 |
| SAT, cm2 | 167 (108) | 166 (98) | −8.7 (55.3) | −29, 9.7 | 0.054 |
†Median (IQR); %; n (%).
NLR, neutrophil-to-lymphocyte ratio; PLR, platelet-to-lymphocyte ratio; LMR, lymphocyte-to-monocyte ratio; PNI, prognostic nutritional index. SMA, skeletal muscle area; SMI, skeletal muscle index; SAT, subcutaneous adipose tissue; VAT, visceral adipose tissue. Bold values indicate statistical significance.